Pharma Focus Asia

Repligen

LATEST NEWSRead more...

25

Jun 2024

Biond Biologics Begins Phase 1 Clinical Trial, Administers First Dose of BND-35

Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient at the Institute of Oncology Davidoff Center Rabin...

25

Jun 2024

GSK's Omjjara (Momelotinib) Receives Approval in Japan for Treating Myelofibrosis

GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type

25

Jun 2024

ANI Pharmaceuticals Plans to Expand Its Rare Disease Business by Acquiring Alimera Sciences

ANI Pharmaceuticals Inc and Alimera Sciences Inc have announced a definitive agreement where ANI will acquire Alimera for per share in cash at closing along with a contingent value right

25

Jun 2024

SK Bioscience and Sanofi Receive IND Approval for Phase 3 Global Clinical Trial of Next-Generation Pneumococcal Vaccine

SK Bioscience and Sanofi have reached a significant milestone with the approval of the global Phase clinical trial plan for their valent pneumococcal conjugate vaccine candidate GBP

24

Jun 2024

AstriVax Begins Clinical Trials for Innovative Vaccine Platform Technology

AstriVax has commenced a Phase I clinical study to assess the safety and effectiveness of its prophylactic vaccines for yellow fever and rabies in healthy adults This initial human trial called SAFYR aims to provide essential safety and immunogenicity data which will be crucial for advancing

Solovpe

press releasesRead more...

25

Jun 2024

Superlab Suisse Opens State-of-the-art Facility in Basel, Fostering New Spaces for Scientific Breakthroughs

For life sciences and biotech companies access to affordable dedicated lab spaces is hard to come by Labs are prohibitively expensive to build and operate posing significant financial barriers to innovation

25

Jun 2024

Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established

Bota Bio a global industrial biotechnology company specializing in sustainable biomanufacturing solutions and NHU a global leader in the fine chemical industry have announced the successful commercialization

25

Jun 2024

Sun Pharma Completes Taro Merger

Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd with its subsidiary As part of this merger Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliate...

25

Jun 2024

GlycoNex Enhances Global Intellectual Property Estate for GNX102 with Patent Approvals in Japan, South Korea, Russia and Taiwan

GlycoNex a clinical stage biotechnology company focused on the development of glycandirected cancer therapies today announced that multiple global patents have been issued for GNX in Japan South Korea

24

Jun 2024

Pacific Northwest Research Institute Uncovers Hidden DNA Mechanisms of Rare Genetic Diseases

Researchers at the Pacific Northwest Research Institute and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders

24 - 25

Jun 2024

25 - 26

Jun 2024

Asia Healthcare Week (AHW)

Suntec Convention & Exhibition Centre, Singapore

25 - 27

Jun 2024

3rd World ADC Asia

Incheon, South Korea

26 - 27

Jun 2024

Future Labs

Basel, Switzerland

26 - 27

Jun 2024

29 - 30

Jun 2024
Cytiva - Supor Prime filters
MFA + MMA 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 4

    Harnessing Artificial Intelligence

    Anita-Ioana Visan

    Scientific Researcher 2nd degree, Laser-Surface-Plasma Interactions (LSPI) Laboratory

    Irina Negut

    Scientific Researcher 2nd degree, National Institute for Lasers, Plasma and Radiation Physics (INFLPR)

KNOWLEDGE BANK

  • Interviews

    Accelovance China

    President

    Asia has had a dramatic spike in interest for medical research pharma advancement and global investment China and India are emerging as leaders in clinical trials They recruit patients faster cheaper and are better than Europe South America or the US because the economies are encouraging more research
  • Articles

    When Orphan Drugs Make All the Difference

    Orphan drugs those medications that are typically produced in small quantities for limited patient populations are growing in importance worldwide Once largely considered too costly to produce given the limited number of patients affected by a particular disease new technology and new breakthroughs in biopharma have changed the landscape allowing more orphan dru

EDITORIAL SECTION